MedPath

Prevalence of Malnutrition in Surgery

Conditions
Malnutrition
Surgery
Cancer
Registration Number
NCT03926715
Lead Sponsor
Società Italiana di Nutrizione Clinica e Metabolismo
Brief Summary

Nutritional disorders are highly prevalent in gastrointestinal cancer patients undergoing surgery and have shown to contribute significantly in short, mid and long-term clinical outcome. Although increasing evidence and expert suggestions there is still inadequate awareness about the clinical relevance of nutritional and metabolic alterations in surgical oncologic patients.

Detailed Description

Nutritional disorders are highly prevalent in cancer patients and have shown to contribute significantly in short-, mid- and long-term clinical outcome. The prevalence of malnutrition is reported between 25% and over 70% based on nutritional assessments. Nutritional disorders represent an important risk factor for the occurence of postoperative complications.

Main obstacles to improving nutritional care include lack of awareness for the problem among the general public and lack of awareness among decision makers and even care providers.

Considering the high prevalence of malnutrition and its repercussions in patient morbidity-mortality and healthcare cost, nutritional screening measures must be included in an integrated nutritional care plan for patients before surgery and while in the hospital.

The PRoMiS study was conceived to quantify nutritional disorders among gastrointestinal cancer patients undergoing surgery in Italy. The data obtained will contribute to increase the awareness of nutritional disorders among oncology surgical patients and their impact on clinical outcome, favoring the inclusion of the initial assessment of nutritional status before surgery and of the nutritional intervention.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
700
Inclusion Criteria
  • Patients who are candidates for surgery for gastrointestinal cancer (esophagus, stomach, small intestine, pancreas, biliary tract, colon, rectum, liver)
  • Diagnosis of malignant solid tumor
  • Age> 18 years
  • Informed consent
Exclusion Criteria
  • Uncontrolled metabolic disorders
  • Uncompensated heart failure
  • Severe psychiatric disorders
  • Appropriate logistical support for participation in the study.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
MalnutritionPre-operative

Malnutrition will be assessed by Malnutrition Universal Screening Tool (MUST)

Secondary Outcome Measures
NameTimeMethod
Post-operative complicationsHospital discharge (10-15 days)

Incidence of pneumonia, sepsis and dehiscence of the surgical wound.

Trial Locations

Locations (8)

Pof. Romario Fumagalli

🇮🇹

Brescia, Italy

Claudio Pedrazzi

🇮🇹

Reggio Emilia, Italy

Roberto Coppola

🇮🇹

Rome, Italy

Antonio Gasbarrini

🇮🇹

Rome, Italy

Giovanni de Manzoni

🇮🇹

Verona, Italy

Leonardo De Meo

🇮🇹

Catania, Italy

Roberto Caronna

🇮🇹

Rome, Italy

Amilcare Parisi

🇮🇹

Terni, Italy

© Copyright 2025. All Rights Reserved by MedPath